Valeritas Holdings, Inc. (OTCBB:CYGM) Files An 8-K Other Events

Valeritas Holdings, Inc. (OTCBB:CYGM) Files An 8-K Other Events

Story continues below

Item 8.01. Other Events.

On May 4, 2017, Valeritas Holdings, Inc. (the Company) issued a
press release announcing that it had announced clinical data
demonstrating that the use of the V-Go Wearable Insulin Delivery
Device provided significant and sustained A1C reductions and
achieved established glycemic targets in patients with
long-standing uncontrolled type 2 diabetes.
The full text of the press release is filed as Exhibit 99.1
hereto and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number
Description
99.1
Press release dated May 4, 2017.


About Valeritas Holdings, Inc. (OTCBB:CYGM)

Valeritas Holdings, Inc., formerly Cleaner Yoga Mat, Inc., is a commercial-stage medical technology company. The Company is focused on developing technologies for Type 2 diabetes. The Company’s product, the V-Go Wearable Insulin Delivery Device (V-Go), is an insulin delivery device that helps patients with Type 2 diabetes requiring insulin to maintain their target blood glucose goals. V-Go is a disposable insulin delivery device that a patient adheres to his or her skin every 24 hours. V-Go enables patients to closely mimic the body’s normal physiologic pattern of insulin delivery throughout the day and to manage their diabetes with insulin without the need to plan a daily routine around multiple daily injections. The Company has developed V-Go utilizing its h-Patch platform as a patient-focused solution to address insulin therapies. Its h-Patch platform facilitates the subcutaneous delivery of injectable medicines to patients across a range of therapeutic areas.

An ad to help with our costs